June is Alzheimer’s and Brain Awareness Month.Promising research alert!If you watch TV or any screen at all, you’ve probably heard of glucagon-like peptide-1 (GLP-1) receptor agonists, or GLP-1 drugs. The popular prescription weight-loss medications help manage blood sugar and reduce appetite in people living with Type 2 diabetes and obesity. GLP-1 drugs have also been associated with reduced risk for cardiovascular events, kidney events and kidney failure. Now, researchers are hoping to add Alzheimer’s to the list. A recent study found that the GLP-1 drug semaglutide (which you may know as Oz...

1 day ago

On HALO